What patents exist for itraconazole (and what do they cover)?
“Itraconazole” is an older antifungal drug, originally marketed as the brand Sporanox/Sporanox capsules and later with additional formulations. Patent coverage typically covers one or more of these areas: the original drug substance, specific manufacturing processes, and later formulation or dosing innovations (for example, different capsule types, tablet formulations, or improved bioavailability). The exact patents that apply depend on the country and the specific product/formulation being discussed.
When do itraconazole patents expire (and why does timing vary)?
Patent expiration depends on:
- the filing date of each patent in a given jurisdiction,
- whether the patent is for the original active ingredient or a later formulation/process,
- patent-term adjustments and possible extensions (where available),
- and whether exclusivity protections beyond patents apply (for example, regulatory data exclusivity, depending on the country and approval history).
Because the question does not specify a country or formulation (capsule vs. liquid vs. tablet), you may see different “expiration dates” for different rights related to itraconazole.
Can generic itraconazole enter before all patents expire?
Yes, often. Generics may launch once they can be made and marketed legally under applicable rules, which may require that only relevant patents covering the specific reference product/formulation are cleared or expired. Even if some patents remain active, generic companies can sometimes proceed by:
- challenging certain patents,
- relying on the “no longer protected” status of other claims, or
- launching a formulation that does not infringe a still-protected claim.
How to find the specific itraconazole patent you mean
If you want the exact patent numbers and expiry dates, you’ll need at least one of the following:
- the country (US, EU, UK, India, etc.),
- the drug form (e.g., capsules, oral solution, tablets),
- the brand name you’re looking at (for example, Sporanox),
- or the company/ANDA (US) or marketing authorization (EU) you want to match.
If you share the country and brand/formulation, I can narrow down which patent family and what expiration information applies.
Are there ongoing patent disputes involving itraconazole?
Patent disputes are possible with older drugs when different generic applicants challenge different listed patents or when brand owners assert still-active formulation/process claims. Whether itraconazole is currently involved depends on the jurisdiction and the specific listed patents for the reference product.
What if you mean “patent itraconazole” as a treatment/availability question
If your real goal is “when can I get generic itraconazole” or “why is itraconazole still expensive/limited,” the answer is usually driven by:
- whether the specific brand/formulation is still under any enforceable IP,
- local manufacturing and distribution,
- and regulatory/market exclusivities rather than the active ingredient being globally “patented” indefinitely.
Quick clarification so I can give a precise answer
Which one do you mean?
1) Patent expiry for itraconazole in a specific country (which country?), or
2) A specific patent number/family (share the number or link), or
3) When generics can be sold for a specific brand/formulation (share brand/formulation)?
Reply with the country and formulation (e.g., “US itraconazole capsules (Sporanox)”), and I’ll target the exact patent(s) and dates.